Sevabertinib
22615
Phase 3 small_molecule active
Quick answer
Sevabertinib for Advanced Non-small Cell Lung Cancer is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Advanced Non-small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active